Related Experiment Video
Updated: Aug 23, 2026
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Prevention of glomerular crescent formation in glomerulonephritis by mycophenolate mofetil in rats
Shin-ichi Takeda1, Masafumi Takahashi, Yoshikazu Sado
1Division of Organ Replacement Research, Center for Molecular Medicine, Jichi Medical School, Minamikawachi-machi, Tochigi 329-0498, Japan.
Background:
Glomerular crescent formation is a prominent feature of aggressive forms of glomerulonephritis (GN) and is associated with a poor prognosis. We investigated whether the potent immunosuppressive agent mycophenolate mofetil (MMF) could prevent crescent formation in a model of anti-glomerular basement membrane (GBM) GN in the rat.
Methods:
GN with glomerular crescents was induced by the injection of anti-GBM antibody to female Wistar-Kyoto (WKY/NCrj) rats. The experimental rats were divided into two groups: rats received vehicle (0.5% carboxymethylcerlose) or MMF (20 mg/kg/day) orally. Body weight was measured and the urine and blood samples were evaluated. The rats were sacrificed at day 14, and histological analysis was performed. The mRNA expression of cytokines and adhesion molecules in the kidney was analysed by reverse transcription-polymerase chain reaction (RT-PCR).
Results:
Marked proteinuria, glomerular crescent formation and glomerulosclerosis were observed in this model, and these were significantly reduced by MMF treatment. Marked glomerular macrophage and T-cell infiltration was also observed, and MMF treatment significantly inhibited macrophage but not T-cell infiltration. RT-PCR and immunohistochemical analysis revealed that mRNA and protein expression of osteopontin was decreased by the treatment with MMF. In addition, MMF treatment in the early stages of GN could inhibit proteinuria, glomerular crescent formation and glomerulosclerosis.
Conclusions:
These findings suggest therapeutic potential for MMF in the inhibition of glomerular crescent formation in GN and provide new insights into the mechanism underlying the amelioration of crescentic GN by MMF treatment.
Insights
Mycophenolate mofetil (MMF) significantly reduced glomerular crescent formation and proteinuria in a rat model of anti-glomerular basement membrane (GBM) glomerulonephritis (GN). MMF treatment also inhibited macrophage infiltration and osteopontin expression, suggesting therapeutic potential for crescentic GN.
Area of Science:
- Nephrology
- Immunology
- Pharmacology
Background:
- Glomerular crescent formation is a hallmark of severe glomerulonephritis (GN) with poor prognosis.
- Investigating novel immunosuppressants is crucial for treating aggressive GN.
Purpose of the Study:
- To evaluate the efficacy of mycophenolate mofetil (MMF) in preventing crescent formation in anti-GBM GN.
- To elucidate the mechanisms underlying MMF's effects on crescentic GN.
Main Methods:
- Anti-GBM GN was induced in Wistar-Kyoto rats.
- Rats were treated with MMF or vehicle, and outcomes assessed via histology, urine/blood analysis, and RT-PCR.
- Kidney tissue was analyzed for cytokine and adhesion molecule mRNA expression.
Main Results:
- MMF treatment significantly reduced proteinuria, crescent formation, and glomerulosclerosis.
- MMF inhibited glomerular macrophage infiltration and osteopontin expression.
- Early MMF intervention ameliorated key pathological features of GN.
Conclusions:
- Mycophenolate mofetil demonstrates therapeutic potential in inhibiting glomerular crescent formation in GN.
- MMF may exert its beneficial effects by modulating macrophage infiltration and osteopontin expression.
